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Abstract
Regulatory T cells (Treg) contribute to the crucial immunological processes of self-tolerance and immune homeostasis.
Genomic mechanisms that regulate cell fate decisions leading to Treg or conventional T cells (Tconv) lineages and those
underlying Treg function remain to be fully elucidated, especially at the histone modification level. We generated high-
resolution genome-wide distribution maps of monomethylated histone H3 lysine 4 (H3K4me1) and trimethylated H3K4
(H3K4me3) in human CD4
+CD25
+FOXP3
+ Tregs and CD4
+CD25
+FOXP3
2 activated (a)Tconv cells by DNA sequencing-by-
synthesis. 2115 H3K4me3 regions corresponded to proximal promoters; in Tregs, the genes associated with these regions
included the master regulator FOXP3 and the chemokine (C-C motif) receptor 7 (CCR7). 41024 Treg-specific H3K4me1
regions were identified. The majority of the H3K4me1 regions differing between Treg and aTconv cells were located at
promoter-distal sites, and in vitro reporter gene assays were used to evaluate and identify novel enhancer activity. We
provide for the first time a comprehensive genome-wide dataset of lineage-specific H3K4me1 and H3K4me3 patterns in
Treg and aTconv cells, which may control cell type-specific gene regulation. This basic principle is likely not restricted to the
two closely-related T cell populations, but may apply generally to somatic cell lineages in adult organisms.
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Introduction
The CD4
+CD25
+FOXP3
+ regulatory T (Treg) cells are re-
quired for proper maintenance of immunological self-tolerance
and immune homeostasis [1]. Treg cells develop in the thymus as
an independent CD4
+ T cell lineage [2–4]. It is believed
that epigenetic modifications serve as an important regulatory
mechanism that mediates cell fate choice between the conven-
tional T (Tconv) cells and Tregs, but there is a paucity of
information related to the epigenetic changes that occur during
Treg differentiation.
Epigenetic modifications, such as methylation, acetylation and
phosphorylation of histones, are implicated in regulating gene
expression by controlling chromatin structure and facilitating
DNA accessibility [5,6]. In T cells, histone modifications and
nucleosome positioning have been correlated with gene expression
or repression [7–11]. The functional program of Treg cells has
been demonstrated to be, at least partially, controlled by miRNA
epigenetic modulation [12–14]. Moreover, constitutive gene
expression of the Treg lineage-directing transcription factor (TF)
forkhead box P3 (FOXP3) has been found to be dependent
upon the DNA methylation status of its cell-specific enhancer [15–
18].
More than 100 differentially methylated regions (DMRs) have
been identified in Treg or Tconv cell type-specific or highly
expressed genes such as FOXP3, interleukin 2 receptor alpha
(IL2RA), CTL-associated molecule-4 (CTLA4), CD40 ligand
(CD40LG) and interferon gamma (IFNG) [19]. Unfortunately,
very little information has been gleaned about the regulatory role
of histone methylation during Treg lineage commitment, differ-
entiation or cell type-specific gene regulation. Determining the
global methylation profile in the distinct T cell lineages, as related
to gene expression status and regulatory regions, such as
promoters and enhancers, will provide significant insight into
differentiation and lineage commitment processes and Treg-
specific function.
General studies on histone acetylation have revealed that this
particular modification is associated with the euchromatin form of
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histone methylation has exhibited a more complex relationship
with chromatin states [7,20]. The monomethylations of one of the
four core histones, H3, at lysines 27, 9 (H3K27, H3K9), H4K20,
and H2BK5 are all linked to gene activation, whereas trimethyla-
tions of H3K27 and H3K9 are linked to repression [7,20,21]. As
for H3K4, both monomethylation and trimethylation are linked to
gene activation [7,20,21].
Acetylation has been found to be enriched in the promoter
regions and at the 59-ends of coding regions. Within the
promoters, the two nucleosomes that flank the transcription start
sites (TSSs) are hypoacetylated at certain lysines and are enriched
in the histone H2A variant Htz1 in yeast [22–26]. In yeast
genome, the TSSs themselves are devoid of nucleosomes [27].
However, nucleosome occupancy in promoter regions (and at the
TSS) is dependent on Pol II occupancy in the human genome
[10,28]. Three forms of histone methylation, monomethylated
histone (H3K4me1), the dimethylated form (H3K4me2) and the
trimethylated form (H3K4me3), have been characterized as
strongly enriched around the TSSs, whereas H3K36me3 peaks
near the 39-ends of genes [29–31].
The chromatin immunoprecipitation-sequencing (ChIP-
Seq) technique developed in recent years combines the use of
modification-specific antibodies for ChIP with next-generation
high-throughput sequencing-by-synthesis, and has revolutionized
our ability to monitor the global incidence of histone modifications.
ChIP-Seq profiles for protein–DNA association have been success-
fully used to identify distal and proximal regulatory elements with
highspatial resolution [7]. In this study, we aimed to take advantage
ofthefine resolutionaffordedbytheChIP-Seqassaytogenerate,for
the first time, genome-wide distribution profiles of H3K4me1 and
H3K4me3 in human Treg cells and activated (a)Tconv cells.
Previous ChIP analysis followed by microarray sequencing-by-
hybridization of the 1% of the human genome represented by the
ENCODE regions indicated that H3K4me1, but not H3K4me3,
was enriched around distal cis-elements for the E1A binding protein
p300 (EP300), while both modifications were enriched at promoters
[32]. Furthermore, the chromatin state at promoters was found to
be largely invariant across diverse cell types. In contrast, the
enhancers identified in different cell types appeared to have cell
type-dependent chromatin modification patterns [33], and the cell
type-specific presence of chromatin marks at enhancers, such as of
H3K4me1, was closely correlated with cell type-specific expression
of the putative gene targets of these enhancers [34]. Thus,
enhancers may be more dynamically regulated in different cell
types and are likely principal mediators of cell type-specific gene
expression. Using the global profile of methylation distribution in
Tregs and aTconv cells, we also aimed to discover novel enhancer
regions that mediated differential gene expression.
Here we present the comprehensive genome-wide dataset of
lineage-specific H3K4me1 and H3K4me3 patterns in Treg and
aTconv cells. The majority of the H3K4me1 regions found to
differ between Treg and aTconv cells were located at promoter-
distal sites. In vitro reporter gene assays were used to evaluate and
identify novel enhancer activity. These global methylation profiles
represent a crucial foundation from which future studies will
elucidate the genetic mechanisms that regulate differentiation
decisions, lineage commitment and gene regulation in Tregs.
Materials and Methods
Cell purification and culture
Mononuclear cells (MNCs) were isolated from leukapheresis
products of healthy volunteers by density gradient centrifugation
over Ficoll-Hypaque solution (Biochrome AG, Germany).
CD4
+CD25
+ T cells were enriched using the human CD4
+CD25
+
Regulatory T Cell Isolation Kit and the Midi-MACS separation
system (both by Miltenyi Biotec, Germany). The isolated
CD4
+CD25
+ T cells were then stained with CD4-FITC and
CD25-PE (both from BD Biosciences, USA), and their purity was
detected with a FACS-Aria high-speed cell sorter (BD Biosciences).
The purity of cells after sortings was determined to reach above
98%.
MACS-purified CD4
+CD25
+ regulatory T cell populations were
monoclonally expanded in vitro over a period of eight to nine weeks
using the DynabeadsH Human Treg Expander (Invitrogen, USA).
Briefly, isolated cells were stimulated with magnetic polysterene
beads coated with a mixture of monoclonal antibodies against CD3
and CD28 in the presence of high-dose recombinant human IL-2
(rhIL-2, 300 U/mL: Proleukin; Chiron, USA), as described in the
manufacturer’s instructions. The expanded cells were then stained
with cell surface anti-CD4-FITC, anti-CD25-PE antibodies and
intracellular anti-FOXP3-APC antibody (eBioscience, USA), and
the fixed cells were separated by fluorescence activated cell sorting
(FACS) into batches of CD4
+CD25
+FOXP3
2 activated Tconv
(aTconv) and CD4
+CD25
+FOXP3
+ regulatory T cells.
Jurkat cells (human T cell leukemia) were grown in 90% 1640-
RPMI (PAN Biotech GmbH, Germany) plus 10% fetal bovine
serum (FBS) supplemented with 2 mM L-glutamine (Biochrome,
Germany), MEM non-essential amino acids, sodium pyruvate,
MEM vitamins, 50 U/mL penicillin/streptomycin, and 50 nM
beta-mercaptoethanol (all from Gibco, USA) in a humidified
atmosphere at 37uC and 5% CO2.
Written, informed consent was obtained from all subjects prior
to participation, and this study was approved by the ethics
committee of the Third Military Medical University, Chongqing,
China.
Suppression assay
CD4
+CD25
- T cells selected from PBMCs with anti-CD4
MACS-beads were labeled with 2 mM of the intracellular
fluorescent dye 5-(and -6)-carboxyfluorescein diacetate succini-
midyl ester (CFSE; Invitrogen) for 10 minutes at 37uC, and
washed twice with PBS. Aliquots of 2610
4 sorted CD4
+CD25
2 T
cells were seeded in wells on a 96-well U-bottom plate pre-coated
with anti-CD3 (2 mg/mL; BD Biosciences) and co-stimulated
with either soluble anti-CD28 (1 mg/ml; BD Biosciences) alone or
in the presence of expanded CD4
+CD25
+ T cells at different
ratios, as indicated. Co-cultures were harvested after four to five
days of incubation and analyzed on a FACS Calibur flow
cytometer.
ChIP and ChIP-Seq
The procedure of ChIP-Seq was carried out as previously
described [7]. The Treg and aTconv cells were used for ChIP
analysis. To map enzyme target sites, 2610
6 cells were crosslinked
with formaldehyde and sonicated to obtain chromatin fragments
of 200 to 300 bp. Sonicated chromatin was pre-cleared and
incubated with 2 mg of anti-H3K4me1 (Abcam, United Kingdom),
anti-H3K4me3 (Abcam) or anti-rabbit IgG (Upstate, USA)
overnight at 4uC. The crosslinks were reversed, and DNA was
treated sequentially with Proteinase K and RNase A, and purified
using the Qiaquick PCR-purification kit (Qiagen, Germany). ChIP
samples were tested for enrichment by qPCR. For ChIP-Seq, the
precipitated DNA was repaired using PNK and Klenow enzyme,
and ligated to adapters according to manufacturer’s instructions.
Subsequently, PCR-amplified fragments of approximately 220 bp
were sequenced using the Solexa 1 G Genome Analyzer following
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have been now accessible in NCBI’s Gene Expression Omnibus
(GSE26427).
ChIP-seq reads mapping to genomic regions
ChIP-seq reads of ,35 bp were mapped to the University of
California, Santa Cruz (UCSC) human genome (hg18) by SOAP,
which allowed a uniquely aligned read to have up to two
mismatching bases [35,36]. The output of the SOAP analysis data
was converted to browser-extensible data (BED) files in order to
view the data in the UCSC Genome Browser [37].
Identification of H3K4me1 and H3K4me3 peaks
The uniquely aligned reads by SOAP were considered in peaks
calling. To eliminate noise and account for unequal total numbers,
we used a defined analysis model (Model-based Analysis of ChIP-
Seq, MACS) with default parameters to find peaks , which were
called ‘‘peaks’’ of H3K4me1 and H3K4me3 [38]. The results
include peak location, peak sequence, etc.
Distribution of H3K4me1 and H3K4me3 peaks
The overall profile of the H3K4me1 and H3K4me3 distribution
was generated by dividing the human genome into four regions
[39]: proximal promoters (1 kb upstream and downstream of the
transcription start site (txStart), based on annotated ‘‘known
genes’’ from the UCSC Genome Browser [37]); exons; introns;
and intergenic sequences.
Identification of common and lineage-specific H3K4me1
and H3K4me3 peaks
We compared the location of each peak in Treg and aTconv
cells for H3K4me1 and H3K4me3. For identification of common
peaks, the location of peaks has to be overlapped in both lineages
with a minimal distance of 1 bp. Furthermore, the lineage-specific
peaks were defined as peaks in one lineage that did not overlap
with any other peaks in the other lineage.
Identification of common and lineage-specific proximal
promoters or genes
Proximal promoters enriched by H3K4me3 in the two lineages
were compared each other to determine the common and cell-type
specific proximal promoters. As a single proximal promoter is
usually associated with one or more genes, we compared the
gene(s) associated with each of the proximal promoters in each cell
type to determine the common and cell-type specific genes.
Profiles of the tag density of modifications
For each gene, uniquely mapped tags (reads) were summed in
125bp windows (40 windows per region) for the regions ranging
from 5 kb upstream of txStart to the txStart itself and from the
transcription end site (txEnd) to 5 kb downstream of the txEnd,
respectively. Within the gene body, every gene was splitted into 40
windows. All window tag counts were normalized by the total
number of bases encompassed within the windows and the total
read number from sequencing of the given library [11].
Quantitative real-time PCR
Total RNA was extracted from the expanded and sorted Treg
and aTconv cells by Trizol Reagent (Invitrogen, USA). The
quantity of total RNA was measured by a NanoDrop spectropho-
tometer (Agilent Technologies, USA), and 500 ng was used to
synthesize cDNA with a Reverse Transcription Kit (TaKaRa,
Japan). GAPDH was used as the endogenous control. PCR was
carried out in a 25 ml reaction with 0.5 mM gene-specific primers
(Table S1) and using a SYBR Green Kit (TaKaRa) for 40 cycles in
a Rotor-Gene 6000 (Gene Company Limited, Australia). The
2
2DD CT method was used to calculate expression relative to the
GAPDH housekeeping control [40].
Reporter assays
The selected H3K4me1 and H3K4me3 enriched regions (500–
1000 bp) were PCR-amplified from human genomic DNA and
cloned directly into the pGL3-promoter vector (Promega, USA).
Primer sequences are listed in Table S2. All inserts were verified
by sequencing. One-million Jurkat cells were co-transfected using
DEAE-dextran, with 1.0 mg of each reporter plasmid and
0.15 mg of a Renilla control vector (Promega). After transfection,
cells were left untreated or stimulated with 20 ng/mL PMA and
1 mM ionomycin (1 mg/mL). Triplicate transfections were
harvested after 24 h of incubation. Cell lysates were assayed for
firefly and Renilla luciferase activities using the Dual-Luciferase
Reporter Assay System (Promega) on a Lumat LB9501 luminom-
eter (Berthold, Germany). Firefly luciferase activity of individual
transfections was normalized against the Renilla luciferase activity.
Statistical analysis
The two-tailed Student’s t-test was used in the analysis of
mRNA expression and of luciferase activity. Significance was
defined by a P-value ,0.05.
Results
Expansion and purification of human CD4
+CD25
+FOXP3
+
Treg cells
Due to the low frequency of Treg cells present in peripheral
blood, we expanded the Treg cell population in vitro to obtain
enough cells for analysis. First, we purified CD4
+CD25
+ T cells
from PBMCs of healthy human volunteer subjects by using the
Magnetic-activated cell-sorting method (MACS). The purity
of products was determined to be .93% (Fig. 1A). Then, the
CD4
+CD25
+ T cells were exposed to artificial antigen-presenting
cells for repeated stimulation via CD3 and CD28 in the presence
of high-dose IL-2, which resulted in profound monoclonal
proliferation of up to 1000-fold expansion within an eight to nine
week span (Fig. 1B). We then tested the suppressive activity of the
expanded CD4
+CD25
+ T cells by evaluating their ability to inhibit
the proliferation of autologous CD4
+CD25
2 T cells after
allogeneic stimulation. Results from the mixed lymphocyte
reaction (MLR) assay showed that the proliferation of
CD4
+CD25
2 responder T cells was inhibited, in a dose-dependent
manner, by the expanded CD4
+CD25
+ T cells (Fig. 1C). Because
CD25 is known to be expressed on activated T cells derived from
Figure 1. Expansion and purification of human CD4
+CD25
+FOXP3
+ Treg cells. Panel A, Isolation and purity (% indicated) of CD4
+CD25
+ T
cells from human PBMCs. Panel B, Expansion rates of sorted CD4
+CD25
+ T cells in vitro. Panel C, Evaluation of the suppressive capacity of expanded
cells. Panel D, FACS-sorting of CD4
+CD25
+FOXP3
+ regulatory T cells and CD4
+CD25
+FOXP3
2 T cells after expansion. The purity of each sub-
population is indicated. S:R, Suppressor:Responder ratios
doi:10.1371/journal.pone.0027770.g001
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+CD25
2FOXP3
2 T cells, the expanded CD4
+CD25
+ T cells
were expected to include FOXP3
2 T cells. To obtain high-purity
of CD4
+CD25
+FOXP3
+ Treg cells, which represent the intrinsic
Treg cells, we purified the triple-positive T cells from the
expanded CD4
+CD25
+ T cells by the FACS method, and the
purity of CD4
+CD25
+FOXP3
+ Treg and activated conventional
CD4
+CD25
+FOXP3
2 T cells (aTconv) reached 99.0% and
99.4%, respectively (Fig. 1D).
Direct sequencing analysis of ChIP DNA samples
We used the high-throughput ChIP-Seq approach to generate
genome-wide H3K4me1 and H3K4me3 maps of human
CD4
+CD25
+FOXP3
+ Treg cells and CD4
+CD25
+FOXP3
2
aTconv cells. The sequencing procedure required a one-step
adaptor ligation and limited PCR amplification (18 cycles) of ChIP
DNA molecules, followed by cluster generation and sequencing-
by-synthesis. The read/peak numbers for each library in each cell
type were shown in Table S3.
Prior to and post sequencing on the Solexa 1 G Genome
Analyzer, the ChIP samples were confirmed for the target sites in
both cell types by regular ChIP-qPCR with the indicated primers
(Table S4 and S5) [41]. The qPCR results were highly consistent
with ChIP-Seq data as expected (Fig. S1 and S2).
Genome-wide maps of H3K4me3 modifications in human
CD4
+CD25
+ T cell lineages with or without FOXP3
expression
To obtain an overall picture of the H3K4me3 distribution, we
divided the entire human genome into four distinct regions,
according to the annotated ‘‘known genes’’ from the UCSC
Genome Browser [37,39]: proximal promoters (1 kb upstream and
downstream of the TSSs), exons, introns, and intergenic
Figure 2. Distribution and tag density of H3K4me3 enriched peaks. Panel A, An illustration of the four regions that the human genome was
divided into: proximal promoters, exons, introns, and intergenic sequences [39]. The number of islands detected for each sample is listed (Total),
followed by the islands among genomic regions with the percentage they comprise listed in the parenthesis. Panel B, Tag density of H3K4me3
enriched peaks in Treg and aTconv cells. Tag density was plotted by splitting upstream (5Kb), downstream(5Kb) and gene body into 40 windows,
respectively. Tag density=number of reads in specific region/(reads total number6specific region length).
doi:10.1371/journal.pone.0027770.g002
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islands were located in proximal promoter regions for Treg cells
and aTconv cells, respectively (Fig. 2A). Examination of those
H3K4me3 tags (reads) located within gene bodies, and their 59-
and 39-end 5 kb extended regions, also revealed enrichment of
H3K4me3 islands near TSSs (Fig. 2B). These results are consistent
with recent observations from others that have indicated that
H3K4me3 associates extensively with proximal promoters of
active genes in human T cells, as well as in human and murine
embryonic stem cells [7,20,42–44].
We compared the H3K4me3 enriched regions between Treg
and aTconv cells, and found that the coefficient correlation was
0.92 and that there were 20784 H3K4me3 islands that overlapped
in the two cell types (Fig. 3A and B). Furthermore, about 75% of
these overlapping islands were located in proximal promoters
(Fig. 3E). We then compared the H3K4me3 enriched proximal
promoters of Treg and aTconv cells, and determined that the
coefficient correlation was 0.83 and that there were 15508
overlapping H3K4me3 enriched proximal promoters (Fig. 3C
and D). In addition to these overlapping islands we also found
that nearly 30000 H3K4me3 islands were Treg cell-type specific,
and about 7% of those were associated with proximal promoters
(Fig. 3B and D). We also analyzed the particular genes related to
the H3K4me3 enriched proximal promoters, and found that most
of the genes were common between the two cell types; only 1220
related genes were Treg cell-type specific (Fig. 3F). These results
suggested that most of the genes were expressed in both Treg cells
and aTconv cells, and the distinct properties of development and
function of Treg cells might, in fact, be due to the unique
H3K4me3 modification of Treg cell type-specific genes like
FOXP3.
Disparate H3K4me3 modification of signature genes
between Treg and aTconv cells
Because the T cell subsets represented distinct and stable cell
lineages, we inferred that the signature genes corresponding to
their respective phenotypes would harbor unique H3K4me3
marks in their proximal promoters, consistent with the corre-
sponding gene expressions in that particular lineage. We first
examined the H3K4me3 pattern for IL2RA, CTLA4, TNFRSF18
and FOXP3 genes, each of which encodes the defining lineage
markers for Treg cells. Results showed that IL2RA, CTLA4 and
TNFRSF18 genes were marked in their promoters by H3K4me3
in both Treg and aTconv cells; this finding was consistent with
their respective expression levels detected in activated T cells
derived from CD4
+CD25
2 T cells (Fig. S3A-C). In contrast,
FOXP3, a gene that is required for Treg cell development and
functions, was marked in its proximal promoter by H3K4me3 in
Treg cells, but not in aTconv cells (Fig. 4A). We detected a 50-fold
increase in the expression level of FOXP3 mRNA in Treg cells, as
compared to aTconv cells; comparable expression levels of
IL2RA, CTLA4 and TNFRSF18 mRNA were observed between
the two cell types (Fig. 4C).
We also examined the mRNA expression levels of other genes
that were found to be marked in their proximal promoters by
H3K4me3 in Treg and/or aTconv cells, such as the STATs and
CCR7. The mRNA expression levels of these genes were
consistent with the H3K4me3 status observed for their proximal
promoter. For example, STAT family TFs are crucial for proper T
cell differentiation; however, their expression is not sufficient to
drive lineage commitment [39]. Consistent with their ubiquitous
expression patterns, we found that most STATs were marked in
their promoter regions by H3K4me3, in both the Treg and
aTconv cells (Fig. S3D-I). Real-time PCR assays showed that the
mRNA expression levels of all the STATs were comparable
among the two lineages (Fig. 4C). In contrast, the promoter for the
CCR7 gene was marked by H3K4me3 only in Treg cells (Fig. 4B),
and the real-time PCR assay showed an approximate 20-fold
increase in its expression as compared to that in aTconv cells
(Fig. 4C). Based on the above results, we predict that Treg
differentiation and lineage commitment are associated with
specific H3K4me3 events in the 1220 cell-type specific genes
(Fig. 3F) that were marked in their proximal promoters by
H3K4me3 only in Treg cells and not in aTconv cells.
Apart from the H3K4me3 islands in promoters, there were
about 60% H3K4me3 islands located in non-promoter regions, a
finding which may be indicative of enhancers [7,11]. Two regions
of particular interest were the intragenic H3K4me3 islands located
about 6 kb (ChrX:49001600-49002200) and 4 kb (ChrX:
49004100-49005100) downstream of the FOXP3 promoter in
Treg cells (Fig. 4A). By using online tool ‘‘TFSEARCH: Searching
Transcription Factor Binding Sites (ver 1.3)’’[45], we found both
islands contained multiple TF target sites, including those for
p300, AML1 and STATs. As such, this region may serve as an
enhancer to regulate the transcription of the FOXP3 gene in Treg
cells.
Genome-wide maps of H3K4me1 modifications in human
CD4
+CD25
+ T cell lineages with or without FOXP3
expression
Previous studies have suggested that H3K4me1 at promoter-
distal sites is often associated with the presence of an enhancer
[7,11,32]. We, thus, generated genome-wide H3K4me1 maps in
human Treg and aTconv cells to compare the predicted enhancers
in both cell types. Results showed that more than half of the total
identified H3K4me1 islands were located in introns in both
aTconv and Treg cells (Fig. 5A). Interestingly, examination of
those H3K4me1 tags found within gene bodies and their 59- and
39-end 5 kb extended regions also revealed that the H3K4me1
enrichment status of proximal promoters was higher than those in
other regions (Fig. 5B).
When comparing the H3K4me1 enriched regions in Treg and
aTconv cells, we found that the coefficient correlation was only
0.48 and there were only 8897 overlapping H3K4me1 islands
present among the 115391 total regions between both cell types
(Fig. 5C and D). These results indicated that most of the
Figure 3. Comparison of H3K4me3 enriched regions, proximal promoters or related genes between Treg and aTconv cells. Panel A,
Correlation of H3K4me3 enriched regions between Treg and aTconv cells. Each spot represents a peak. The X- and Y-axis represent the ratio of the
total reads of the H3K4me3 enriched peak to the length of the proximal promoter of this gene in Treg or aTconv cells, respectively. Panel B,
Overlapping H3K4me3 enriched regions between Treg and aTconv cells. Panel C, Correlation of proximal promoters marked by H3K4me3 between
Treg and aTconv cells. Each spot represents an individual peak. The X- and Y-axes are the same as for Panel A. Panel D, The high degree of
overlapping proximal promoters marked by H3K4me3 between Treg and aTconv cells. Panel E, Summary of the distribution of overlapping regions
enriched by H3K4me3 in Treg and aTconv cells. Panel F, Venn diagram showing the difference of genes associated with H3K4me3 enriched proximal
promoters between Treg and aTconv cells.
doi:10.1371/journal.pone.0027770.g003
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suggested that enhancers represent the most variable class of
transcriptional regulatory element between Treg and aTconv cells,
and were probably primary mediators of Treg cell-type specific
patterns of gene expression.
H3K4me1 modifications of cell signature genes and
verification of enhancer activity
Among the 18081 total genes that were H3K4me1 modified in
Treg cells (Fig. 5A), we selected a subset of the cell signature genes
to further examine the H3K4me1 patterns and verify the activities
of enhancers predicted to be related to these genes. The signature
gene subset included IL2RA, CTLA4, TNFRSF18 and FOXP3
genes, which are known to be highly or specifically expressed in
Treg cells. We identified some Treg cell-specific H3K4me1
regions, including: a region in intron 1 of FOXP3 that was also
enriched by H3K4me3 (Fig. 4A and 6A) [ChrX:49001620–
49002192]; a region in the last exon of FOXP3 (Fig. 6A)
[ChrX:48994400–48995097]; a region in intron 2 of the CTLA4
(Fig. S3J) [Chr2:204444600–204445077]; a region in intron 1 of
IL2RA [Chr10:6136100–6136695] and a region upstream of
IL2RA (Fig. S3K) [Chr10:6148000–6148784]. We were unable to
identify any Treg cell-specific H3K4me1 regions for the
TNFRSF18 gene (Fig. S3L).
Previous studies have suggested that H3K4me1 at promoter-
distal sites are often associated with enhancer function. A general
property of such enhancers is the ability to increase transcriptional
activity in a heterologous context. As this type of function can be
readily studied using traditional reporter gene assays, we selected
the five Treg cell-specific H3K4me1 regions described above to
evaluate their heterologous enhancer activities. As shown in
Figure 6B, only two of the five regions examined showed enhancer
activity. Interestingly, the majority of regions that did not show
enhancer activity in Jurkat cells corresponded to Treg cell-specific
H3K4me1 enriched regions. In line with this finding, a H3K4me1
region in intron 1 of the IL2RA gene (Fig. S3K) [Chr10:6131603–
6132187] and a H3K4me1 region upstream of the TNFRSF18
gene (Fig. S3L) [Chr1:1133645–1134389], which were enriched in
both Treg and aTconv cells, did exhibit enhancer activity in Jurkat
cells (Fig. 6C). Since Jurkat T cells represent a leukemic
counterpart of conventional T cells, it is very possible that they
lack Treg cell-specific TFs that are necessary for enhancer
functions of these particular regions. However, some Treg cell-
specific H3K4me1 regions did function even in Jurkat cells,
suggesting that the relevant TFs required for enhancer activity at
these sites were, at least, available.
Comparison of H3K4me3 and H3K4me1 enriched regions
in Treg or aTconv cells
We also compared the H3K4me1 and H3K4me3 enriched
regions in the same sample, and determined that the coefficient
correlation was only 0.16 in Treg cells and 0.19 in aTconv cells.
Furthermore, there were only 5030 overlapping H3K4me1
regions and 7063 overlapping H3K4me3 regions (Fig. 7). These
results indicated that H3K4me1 modified regions with potential
regulatory function were seldom overlapped with H3K4me3
modified regions in the whole genome of human Treg and aTconv
cells.
Discussion
In this study, we obtained high-purity of human
CD4
+CD25
+FOXP3
+ Treg cells and aTconv cells by combining
in vitro expansion, MACS- and FACS- sorting methods (Fig. 1). As
reported by other researchers employing this technique, these cells
maintained all phenotypic, functional and epigenetic Treg cell
characteristics, even after extensive in vitro expansion [46,47]. We
utilized these cells for ChIP-Seq analysis to generate high-
resolution maps of the genome-wide distribution of H3K4me1
and H3K4me3 in both cell subtypes. Ultimately, we identified a
number of cell type-specific H3K4me1 regions and H3K4me3
marked proximal promoters in Treg cells. The majority of the
differential H3K4me1 regions were found to be located in
promoter-distal sites, and we selected some for verification of
their enhancer activity by using reporter gene assays.
CD4-positivity and CD25-positivity have long been considered
as the cell-specific indicators of Treg cells. However, CD4
+CD25
-
T cells were demonstrated to be able to up-regulate their CD25
expression upon activation by antigen, indicating that CD4 and
CD25 double-positive T cells actually represent a heterogeneous
cell population and these surface markers are not sufficient
identifiers of Treg cells. Thus, we used CD4
+CD25
+FOXP3
+
triple expression to define Treg cells since FOXP3 gene expression
is essential for Treg cell function. We carried out comparative
analysis of the genome wide epigenetic methylation status for
H3K4 in CD4
+CD25
+FOXP3
+ (Treg) and CD4
+CD25
+FOXP3
-
T cells (aTconv).
The low frequency of Treg cells in normal human peripheral
blood has thus far limited the detailed characterization and
potential clinical application of human Treg cells. In many
previous studies, Treg expansion has been carried out to obtain
enough cell material to perform analysis. Unfortunately, CD4 and
CD25 were usually used to identify the Treg cells. Here, we found
that although CD4
+CD25
+ T cells were expanded up to 1000-fold,
most of the expanded cells were FOXP3-negative. Thus, we
performed FACS-sorting to obtain high-purity Treg cells with
CD4, CD25 and FOXP3 expressions immediately prior to our
ChIP-Seq assay.
Previously, Heintzman determined the chromatin modification
states at high resolution along 30 Mb of the human genome, and
found that active promoters were marked by H3K4me3 and
enhancers by H3K4me1 [32]. We also found that most proximal
promoters enriched by H3K4me3 were common between the
Treg and aTconv cells, suggesting that the related genes of the
proximal promoters were co-expressed in the two lineages.
Figure 4. H3K4me3 modifications of cell signature genes and common genes in Treg and aTconv cells, as analyzed by the UCSC
hg18 Genome Browser. The following tracks are shown (from top to bottom): Window position; ChIP-Seq tag counts for H3K4me3 modifications
in Treg cells; ChIP-seq tag counts for H3K4me3 modifications in aTconv cells; UCSC genes based on RefSeq; mammalian consensus. The red frames
indicate the H3K4me3 modifications in proximal promoters. Panel A, H3K4me3 modification on the FOXP3 loci (ChrX:48990000–49010000). The two
intragenic H3K4me3 islands, located about 6 kb (ChrX:49001600–49002200) and 4 kb (ChrX:49004100–49005100) downstream of the FOXP3
promoter in Treg cells, are framed in blue. Panel B, H3K4me3 modification on the CCR7 loci (Chr17:35960621–35978190). Panel C, Expression of cell
signature genes and common genes. The mRNA expression levels of signature genes and common genes are shown for Treg and aTconv cells, as
measured by real-time PCR assays. The 2
2DD CT method is used to quantify the expression relative to the GAPDH housekeeping control. Data are
shown as fold-induction relative to Treg cells and are the mean 6 standard error of the mean (SEM) from three independent experiments. *, P,0.01,
vs Treg cells.
doi:10.1371/journal.pone.0027770.g004
Global Mapping of H3K4me1/me3 in Human Treg Cells
PLoS ONE | www.plosone.org 9 November 2011 | Volume 6 | Issue 11 | e27770Figure 5. Genome-wide distribution and comparison of H3K4me1 modifications between Treg and aTconv cells. Panels A and B,
Distribution and tag density of H3K4me1 enriched peaks. (A) Distribution of H3K4me1 enriched peaks. The number of islands for each sample is
listed as the total identified islands (Total), followed by the islands among genomic regions with the corresponding percentage listed in the
parenthesis. (B) For each gene, uniquely mapped tags were summed in 125 bp windows from 5 kb upstream of the txStart to the txStart, and from
the txEnd to 5 kb downstream. Panels C and D, Comparison of H3K4me1 enriched regions between Treg and aTconv cells. (C) Correlation of
H3K4me1 enriched regions between Treg and aTconv cells. Each spot represents a single peak. The X- and Y-axis represent the ratio of the total reads
of H3K4me1 enriched peak to the length of this gene in Treg or aTconv cells, respectively. (D) Overlapping H3K4me1 enriched regions between Treg
and aTconv cells.
doi:10.1371/journal.pone.0027770.g005
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PLoS ONE | www.plosone.org 10 November 2011 | Volume 6 | Issue 11 | e27770Although some genes are widely used as markers for Treg cells,
such as IL2RA, CTLA4 and TNFRSF18, accumulating evidence
has unfortunately suggested that these markers are not strictly
Treg-specific. Upon activation, all T cells express CD25, the
alpha-chain of the IL-2 receptor [48,49], and its combination with
IL-2 is essential for T cell clonal expansion. CTLA-4, which is the
receptor for APC-B7, negatively regulates the IL-2 production of
the newly activated T cell and inhibits further T cell proliferation
upon binding of B7 and is up-regulated on all CD4
+ and CD8
+ T
cells, two to three days following activation [49,50]. Similarly, the
expression of TNFRSF18, which is a possible target molecule in
cell contact-dependent suppression, is induced in T cells upon
activation [49,51]. This could explain why we observed H3K4me3
in the proximal promoters of these genes in aTconv cells. STAT
family TFs are critical for T cell differentiation; however, their
expression is not sufficient to drive lineage commitment.
Consistent with the ubiquitous expression patterns of STAT
family TFs, we found that most STATs were marked in their
Figure 6. Prediction of enhancers and verification of activity for cell signature genes. Panel A, UCSC hg18 genome browser views of
H3K4me1 modifications of the cell signature gene FOXP3 loci (ChrX:48990000–49010000) in Treg and aTconv cells. The following tracks are shown
(from top to bottom): genes’ location; ChIP-Seq tag counts for H3K4me1 modifications in Treg cells; ChIP-Seq tag counts for H3K4me1 modifications
in aTconv cells; UCSC genes based on RefSeq; mammalian consensus. The blue frames indicate the Treg cell-type specific H3K4me1 enriched regions.
Panels B Functional analysis of enhancer candidates specific for Treg cells. These fragments are all enriched by H3K4me1 modifications except the
FOXP3 (ChrX:49004128–49005080) fragment, which is H3K4me3 modified and identified as an enhancer in the published literatures. Panel C,
Functional analysis of the enhancer candidates common in both Treg and aTconv cells, which are all H3K4me1 modified. All the selected enhancer
candidates were cloned into the luciferase vector pGL3-Promoter, respectively. The indicated plasmids were transiently transfected into Jurkat T cells
that were stimulated with or without PMA and ionomycin (PI) after transfection. Luciferase activity was normalized against the activity of a co-
transfected Renilla construct. Mean values 6 SEM are shown relative to the pGL3-promoter alone. * indicates a statistically significant difference
between the cloned vs control plasmids (P,0.01; paired Student’s t-test).
doi:10.1371/journal.pone.0027770.g006
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PLoS ONE | www.plosone.org 11 November 2011 | Volume 6 | Issue 11 | e27770promoter regions by H3K4me3, in both Treg and aTconv cells.
Based on these results, we predicted that the common 19927 genes
between Treg and aTconv cells (Fig. 3F) may be expressed in both
lineages.
We found that, apart from the common H3K4me3 promoters,
there were also some Treg cell-type specific proximal promoters
marked by H3K4me3, such as FOXP3 (Fig. 4A and C). It may be
these types of specific proximal promoters, especially the FOXP3,
that are responsible for the differences between Treg cell and
aTconv cells. The proximal promoter of FOXP3, which is
believed to serve as a master regulator of Treg cells, was found
to be enriched by H3K4me3 in Treg cells. Moreover, a 50-fold
Figure 7. Comparison of H3K4me1 and H3K4me3 enriched regions in Treg or aTconv cells. Panel A, Correlation of H3K4me1 and
H3K4me3 enriched regions in Treg cells. Each spot represents a single peak. The X-axis represents the ratio of total reads of the H3K4me3 enriched
peak to the length of corresponding gene, while the Y axis represents the ratio of the total reads of the H3K4me1 enriched peak to the length of
corresponding gene. Panel B, Regions enriched by H3K4me1 and H3K4me3 in Treg cells. Panel C, Correlation of H3K4me1 and H3K4me3 enriched
regions in aTconv cells. Each spot represents a single peak. The X- and Y-axes are the same as for Panel A. Panel D, Regions enriched by H3K4me1
and H3K4me3 in aTconv cells. Panel E, Summary of the distribution of the regions enriched by H3K4me1 and H3K4me3 in Treg or aTconv cells.
doi:10.1371/journal.pone.0027770.g007
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PLoS ONE | www.plosone.org 12 November 2011 | Volume 6 | Issue 11 | e27770higher mRNA expression level was observed in Treg cells, as
compared to aTconv cells. This nearly exclusive expression of
FOXP3 in Treg cells was in accordance with the current concept
that FOXP3 represents the critical TF of Treg cells. In addition,
we also found that the CCR7 gene was marked by H3K4me3 in
its proximal promoter only in Treg cells, and exhibited a nearly
20-fold increase of mRNA expression in Treg, as compared to
aTconv cells.
H3K4me3 is usually associated with promoters, and its
occurrence at enhancers remains a topic of debate. Whereas
Heintzman, et al. found little or no H3K4me3 at p300-associated
enhancers [32], Barski, et al. identified all three methylation states
at the related functional enhancers [7]. It is, therefore, unclear
whether the promoter-distal H3K4me3 sites identified in this study
are associated with uncharacterized functional transcription units,
or whether they are able to act as enhancer regions themselves.
For example, we found there was a region located about 6 kb
downstream of the FOXP3 promoter (ChrX:49001620–
49002192), which showed enhancer activity in transient transfec-
tion assays; the existence of this region suggests that there may be
some non-promoter H3K4me3 regions associated with enhancers.
Another region located about 4 kb downstream of the FOXP3
promoter was specifically enriched by H3K4me3 in Treg cells
(ChrX:49004128–49005080), and also exhibited enhancer activ-
ity; interestingly, previous studies have shown that this region was
enriched for STAT5 consensus sites. Treg cell survival critically
depends on interaction with IL-2. The TF STAT5 is activated
through the IL-2 receptor [52], has an essential role in Treg cell
homeostasis [53], and is known to regulate the lineage-specific TF
FOXP3 through an intronic, methylation-sensitive enhancer [54].
Together, all the data indicate that certain promoter-distal
H3K4me3 modified regions may have enhancer activity. More-
over, it is likely that some of the 27000 Treg cell-type specific
H3K4me3 non-promoter regions that were identified in this study
might be important for Treg cell-type specific patterns of gene
expression.
Although the promoter region represents a primary element of
gene expression, it is controlled by distal regulatory elements like
enhancers and silencers. Previous studies have shown that
H3K4me1 at promoter-distal sites was often associated with
enhancer function [7,11,32]. Our results indicated that most of the
H3K4me1 islands were cell-type specific, suggesting that enhanc-
ers are the most variable class of transcriptional regulatory element
between Treg and aTconv cells, and are probably of primary
importance in driving Treg cell-type specific patterns of gene
expression. Our study identified a number of putative regulatory
elements for genes that are highly important for Treg cell
functions. For instance, we found that there was a region located
in intron 1 of the FOXP3 gene (ChrX:49001620–49002192)
enriched by both H3K4me1 and H3K4me3 in Treg cells and
which showed enhancer activity in transfected Jurkat cells. A
region located upstream of IL2RA (Chr10:6148000–6148784) also
showed enhancer activity. Since cultured and expanded conven-
tional T cells express high levels of CD25 as a consequence of
TCR activation, it is possible that this region may contribute to
regulating constitutive (rather than activation-induced) CD25
expression in Treg cells.
In addition, we found that most H3K4me1 enriched regions
were not enriched by H3K4me3, suggesting that most potential
regulatory elements were only enriched by H3K4me1 but lacked
H3K4me3 in the whole genome of human Treg and aTconv cells.
This finding is consistent with the observations of p300-associated
enhancers that were found to have little or no H3K4me3 [32].
However, there were also some regions simultaneously enriched
by H3K4me1 and H3K4me3, such as the region located in intron
1 of the FOXP3 gene, which did show enhancer activity. Whether
or not the regions enriched by the two types of histone
methylations may harbor more potential to act as enhancers
remains unknown.
In conclusion, we identified genome-wide H3K4me1 and
H3K4me3 modification regions in Treg and aTconv cells. The
H3K4me3 modifications located in proximal-promoter regions
were nearly identical in both Treg and aTconv cells, with the
exception of a few promoters of genes, such as FOXP3 and CCR7,
which are expressed uniquely in Treg cells. In contrast to the
H3K4me3 modification, H3K4me1 exhibited cell-type specific
locations, indicating that enhancers are the most variable class of
transcriptional regulatory elements between Treg and aTconv
cells. Furthermore, enhancers are likely to be of primary
importance in driving Treg cell-type specific patterns of gene
expression. The Treg- and aTconv-specific H3K4me1 and
H3K43 patterns may function as significant mediators of
differentiation events, lineage commitment and cell type-specific
gene expression. It is likely that this basic principle is not confined
to these two closely related T cell populations, but may apply
generally to somatic cell lineages in adult organisms.
Supporting Information
Figure S1 Real-time PCR analysis of known target sites
enriched by H3K4me3. ChIP assays were performed with
Tregs and aTconv cells as described. DNA fragments binding to
H3K4me3 histones were immunoprecipitated using antibodies
directed against H3K4me3. The rabbit isotype immunoglobulin G
(IgG) served as control, IgGa was a control for Treg and IgGb was
a control for aTconv. Precipitated DNA was quantified by real-
time PCR with primers specific for the sites of the known cell
signature genes and common genes. Sample PCR products were
set in relation to input DNA. *, P,0.001 vs IgG control; #,
P,0.001 vs aTconv.
(EPS)
Figure S2 Real-time PCR analysis of known target sites
after sequencing. ChIP assays were performed with Tregs and
aTconv cells as described. DNA fragments binding to H3K4me1
histones were immunoprecipitated using antibodies directed
against H3K4me1. The rabbit isotype immunoglobulin G (IgG)
served as control, IgGa was a control for Treg and IgGb was a
control for aTconv. Precipitated DNA was quantified by real-time
PCR with primers specific for the sites of the known cell signature
genes and common genes. Sample PCR products were set in
relation to input DNA. *, P,0.001 vs IgG control.
(EPS)
Figure S3 H3K4me3 and H3K4me1modifications of
signature genes and common genes in Treg and aTconv
T cells. Shown are the following tracks (from top to bottom):
Genes location; ChIP-seq tag counts for H3K4me3 or H3K4mel
modifications in Treg cells; ChIP-seq tag counts for H3K4me3 or
H3K4mel modifications in aTconv cells; UCSC Genes Based on
Refseq; mammalian Consensus. Red frames represent the
H3K4me3 modifications in proximal promoters. Blue frames
represent the Treg cell-type specific H3K4me1 enriched regions
and orange frames represent the H3K4me1 regions enriched in
both Treg and aTconv cells. Panel A, H3K4me3 modification on
IL2RA (Chr10:6095000–6145000) loci. Panel B, H3K4me3
modification on CTLA4 (Chr2:204440000–204448000) loci.
Panel C, H3K4me3 modification on GITR, i.e., TNFRSF18
(Chr1:1128000–1132500) loci. Panel D-I, H3K4me3 modification
Global Mapping of H3K4me1/me3 in Human Treg Cells
PLoS ONE | www.plosone.org 13 November 2011 | Volume 6 | Issue 11 | e27770on STAT1 (Chr2:191540000–191590000), STAT2 (Chr12:
55020000–55045000), STAT3 (Chr17:37720000–37800000),
STAT4 (Chr2:191600000–191750000), STAT5A (Chr17:
37690000–37720000) and STAT6 (Chr12:55775000–55795000)
loci. Panel J H3K4me3 modification on CTLA4 (Chr2:
204440000–204448000) loci. Pane K H3K4me3 modification on
IL2RA (Chr10:6115000–6155000) loci. PaneL H3K4me3 modi-
fication on GITR (Chr1:1125000–1136000) loci.
(TIF)
Table S1 Real-time PCR primers for mRNA expression
of known genes.
(DOC)
Table S2 Primers for the amplification of H3K4me1 or
H3k4me3 enriched regions.
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